Janssen Agrees With Creation Of Invokana MDL, Transfer To New Jersey
Mealey's (October 17, 2016, 12:40 PM EDT) -- WASHINGTON, D.C. — Janssen Pharmaceuticals Inc. on Oct. 12 said it agrees with some plaintiffs that at least 57 federal lawsuits alleging kidney failure or ketoacidosis from the diabetes drug Invokana...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login